# INFUSE®Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine

> **NCT01415908** · PHASE3 · TERMINATED · sponsor: **Medtronic Spinal and Biologics** · enrollment: 15 (actual)

## Conditions studied

- Lumbar Spine Degeneration

## Interventions

- **DEVICE:** INFUSE Bone Graft
- **OTHER:** Iliac Crest Bone Graft

## Key facts

- **NCT ID:** NCT01415908
- **Lead sponsor:** Medtronic Spinal and Biologics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-07
- **Primary completion:** 2014-09
- **Final completion:** 2015-01
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Due to study design challenges including DMC enrollment suspension as required by the protocol stopping rules and recommended changes to the surgical technique
- **Last updated:** 2016-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01415908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01415908, "INFUSE®Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01415908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*